ICU blood test may reveal hidden alcohol risks

NCT ID NCT07632716

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study looks at whether a blood test for a marker of heavy drinking (carbohydrate-deficient transferrin, or CDT) can help predict how well critically ill patients will do in the intensive care unit. Researchers will follow 800 adults admitted to the ICU through the emergency department, tracking their recovery and any complications. The goal is to see if higher CDT levels are linked to a higher risk of death or other serious issues, which could help doctors tailor care for these patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL MISUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Vienna

    RECRUITING

    Vienna, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.